How Long Before Wegovy Starts Working — and What to Expect

What the trial data shows about when Wegovy's effects begin

The STEP 1 trial is the most rigorous evidence we have on semaglutide 2.4mg for weight management. Over 68 weeks, adults with obesity or overweight and at least one weight-related condition lost around 15% of body weight on average alongside a reduced-calorie diet and increased activity. That figure is important context for the timeline question: the results were cumulative, built over more than a year, not front-loaded into the first few weeks.

Looking at the trial's weight trajectory, the sharpest rate of loss occurred broadly in the first 20 weeks, after which progress continued but at a gentler slope. What this tells us practically is that the medicine is working well before most people can see it clearly on the scales. GLP-1 receptor agonists like semaglutide slow gastric emptying and reduce appetite signals, effects that begin influencing how much you eat before significant weight change is visible.

A note our prescribers hear most weeks: "I'm two weeks in and nothing seems to be happening." Usually something is. The starting dose of 0.25mg is a tolerability dose, its job is to let your system adjust, not to produce immediate weight loss. The clinical effects build as the dose increases. Expecting dramatic change at week two sets up unnecessary disappointment; expecting gradual, compounding change over months is far closer to what the evidence shows. You can read more about the full picture on our Wegovy treatment overview.

The dose-titration schedule and why it shapes your timeline

Wegovy's licensed titration pathway starts at 0.25mg weekly and steps up through 0.5mg, 1.0mg and 1.7mg to the standard maintenance dose of 2.4mg, with roughly four weeks at each level. The MHRA approved a higher 7.2mg maintenance option in early 2026, giving prescribers and patients more flexibility for those who need and can tolerate it. The specific dose and timing that applies to you is determined by your prescriber, this schedule is described here factually, not as guidance for your own treatment.

The practical consequence for the timeline question is significant. You are unlikely to be at full therapeutic dose for at least 16 weeks. If you are wondering how long before Wegovy starts to work in a meaningful sense, the slow escalation schedule is a key part of that answer, designed to minimise gastrointestinal side effects such as nausea, indigestion, and constipation that are most common when starting or increasing the dose, while also ensuring the appetite-reducing effects strengthen progressively rather than arriving all at once.

Some people do notice appetite suppression quite early, eating less at meals, feeling full sooner, or simply thinking about food less often. These appetite shifts are real clinical effects, not placebo; they precede the weight loss on the scales. Track these early signals alongside your weight rather than using the scales alone. The NHS England guidance on weight-management injections also emphasises that lifestyle changes alongside the medicine are central to the results you'll see, the drug amplifies the effort, it doesn't replace it.

What 'starting to work' actually means at six, twelve and twenty-four weeks

It helps to break the timeline into rough stages, understanding these are averages and individual variation is wide.

Weeks one to four: appetite signals begin to change for many people. Portion sizes naturally reduce. Some experience nausea or other GI symptoms, particularly in the first week or two after starting or increasing the dose. Weight change is usually modest at this stage.

Weeks four to twelve: with dose increases underway, the appetite-reducing effects strengthen. Many people report a clear shift in how much they want to eat. Weight loss of a few percent of starting body weight is common in this window, though not universal. This is also the period when building sustainable eating habits matters most, the medicine lowers appetite, but food choices still shape the result. For a closer look at how long till Wegovy starts working at a noticeable level, this four-to-twelve-week window is where many people begin to feel a genuine difference.

Weeks twelve to twenty-four: those approaching or at maintenance dose tend to see more consistent weekly losses. This is where trial data shows the steepest cumulative change. If you're wondering how fast Wegovy starts working in terms of visible progress, this period is typically when it becomes most apparent. You can find detail on what the evidence says about fat reduction in particular on our guide to semaglutide and body composition changes.

Beyond six months, the pace usually slows as the body adapts, which is normal. The question of where to buy Wegovy through a regulated, clinically supervised route (rather than any unverified source) matters throughout this whole period, because consistency of supply and ongoing clinical review both affect outcomes. Our guide to sourcing Wegovy safely in the UK covers what to look for.

Factors that affect how quickly Wegovy works for you personally

Clinical trial averages mask genuine individual variation. Several factors influence the pace of response to semaglutide, and understanding them can help you interpret your own early weeks more accurately.

Starting metabolic rate and body composition: people with a higher proportion of metabolically active tissue may respond at a different rate. Neither of these is something you can change directly, but both are reasons why two people on the same dose can have very different early timelines.

Diet quality alongside treatment: semaglutide reduces appetite, but it does not override dietary choices. Higher protein intake helps preserve lean mass during weight loss; adequate fibre supports the gut; hydration matters. The NHS's patient information on semaglutide recommends using the medicine alongside a reduced-calorie diet and increased physical activity, not instead of them.

Consistency and adherence: missing doses slows the build-up of effect. Weekly injections at a consistent day and time help maintain stable levels. The OASIS 4 trial of oral semaglutide found that fully adherent participants lost notably more weight than the trial average, the same logic applies here.

Dose tolerability: if GI side effects are significant enough to require staying on a lower dose for longer, the therapeutic effect builds more slowly. This is the correct clinical response, pushing through severe nausea to reach maintenance dose faster is not. Talk to your prescriber, not the internet, if this is your situation. Our frequently asked questions cover some common concerns in the early weeks. If you'd like a clinical view on whether Wegovy is right for you, check your eligibility with our prescribers through a free consultation.